Hepatic angiosarcomas are rare mesenchymal tumors with few case series and reports describing their imaging findings in the last two decades. The computed tomography and magnetic resonance imaging findings are variable and may appear like hemangioma at one end of the spectrum and hepatoma at the other end. The use of hepatocyte specific contrast on magnetic resonance imaging may also be insufficient in making a reliable imaging diagnosis. These tumors can easily mimic hypervascular liver cancer, atypical hemangioma or metastases. This case report highlights the imaging features of this entity and also underlines that, this tumor should always be considered as a differential diagnosis for hypervascular tumors in cirrhotic patients. The current imaging paradigms for its diagnosis are also discussed.
CASE REPORT
A 71-year-old gentleman was admitted to our hospital with a 1 month progressive history of feeling of lump and heaviness in the right hypochondrium. There was no history of jaundice or fever. No other constitutional symptoms were present. On admission, his physical examination showed a firm lump in the right hypochondrium which was inseparable from the liver margins. His laboratory tests showed a normal Alpha feto protein (AFP) (3.5 U/ml) (reference range: 10-20 ng/ml). The liver function tests including serum bilirubin and liver enzymes were not elevated. The patient subsequently underwent a dynamic triple phase computed tomography (CT) of the abdomen. It showed two, rounded, ill-defined lesions in the early arterial phase with peripheral hypervascularity in the segment-IV and caudate lobe ( Figure 1A ). On portal venous phase (PVP), the caudate lobe lesion appeared hypodense compared to rest of the heterogeneously enhancing liver parenchyma; however the segment IV lesion showed progressive centripetal heterogeneous enhancement. There was no evidence of contrast washout (Figure1B). The liver outlines appeared irregular and lobulated. Magnetic resonance imaging (MRI) was performed with hepatocyte specific contrast (Gadobenate Dimeglumine, Multihance, Bracco). These lesions were moderately T2 hyperintense (Figure 2A ) and demonstrated restricted diffusion on diffusion weighted imaging ( Figure 2B ). On contrast administration, mild early arterial peripheral vascularity around segment-IV, lesion was seen ( Figure 2C ) with progressive filling in of the segment-IV and caudate lobe lesions on PVP and equilibrium phase ( Figures 2D, E) . The liver parenchyma did not reveal any focal hypointense lesions and appeared mildly heterogeneous. It showed diffuse hepatocyte specific contrast enhancement with predominant iso-intense signal on the delayed hepatobiliary phase ( Figure 2F ). Based on the combined imaging findings of dynamic CT and MRI, a diagnosis of an atypical vascular tumor with differential diagnosis of hemangioma, hepatoma and metastases with underlying diffuse liver parenchymal disease was made. The patient however refused biopsy or any sort of intervention and was managed conservatively. After 4 months the patient returned with worsening symptoms and increase in the lump size. A follow up CT showed a massive increase in the size (more than double) of the lesions with multiple new lesions in both lobes of liver ( Figures 3A,B) .The
lesions showed gross arterial hypervascularity ( Figure 3A) . The PVP images revealed multiple ill-defined, predominantly, peripherally enhancing lesions with central areas of hypodensity ( Figures 3C, D) . The liver parenchyma appeared diffusely heterogeneous ( Figure 3D ). The repeat AFP levels were also normal. This time however the patient consented to biopsy, which showed sinusoidal and solid growth pattern with atrophic benign hepatocytes at low power magnification ( Figure 4A ) and atypical endothelial cells displaying irregular hyperchromatic nuclei at high power magnification ( Figure  4B ). On Immunohistochemistry the malignant endothelial cells showed strong CD34 immunostaining ( Figure 4C ) consistent with hepatic angiosarcoma.
The patient was offered chemotherapy which he refused and died within 6 months from the date of diagnosis.
Etiology & demographics
Angiosarcoma is a primary mesenchymal tumor of endothelial cell origin with anastomosing vascular channels. Its hepatic subset is found predominantly in males (male: female ratio of 3:1) [1, 2]. It is usually seen to affect the soft tissues of the scalp, head and neck followed by breast as a secondary tumor in patients who receive radiation therapy [3] . Hepatic angiosarcoma is known to have association with carcinogens including vinyl chloride, thorotrast, and arsenic [4] . Liver is an uncommon site for its origin. The malignancy has a small association with Von Recklinghausen syndrome and hemochromatosis [5, 6] . Of all the primary liver cancers barely 2% are reported to be angiosarcoma; however, it still ranks at the third place in the list of most common primary liver malignancies [4,7-8]. It usually affects the elderly (50-79 years) and has a very poor prognosis with median survival rate of 6 months to 2 years [4, 8] . The treatment options are limited and include surgery if the tumor is resectable, followed by chemotherapy or radiotherapy without significant survival benefits [9 -11] . Early metastases are also a feature of this disease and hence high recurrence with metastasis makes it a difficult tumor to treat even with liver transplant [12] .
Clinical & imaging findings
The clinical symptoms of hepatic angiosarcoma are usually non-specific with abdominal fullness, malaise and fatigue. Liver specific changes in laboratory markers such as bilirubin levels, altered protein-albumin/ globulin ratio or raised liver enzymes are seen only in large tumours or in clinically advanced cases. AFP is not elevated in majority of these cases and physical examination shows firm hepatomegaly [7] . Spontaneous rupture of the tumor in the liver and associated peritoneal hemorrhage is a well-known complication seen in approximately in 27% of patients [8, 13] . Imaging is usually the first step in the investigation with dynamic CT or MRI being the modalities of choice to characterize the lesion and monitor the complications. Hepatic angiosarcoma can present as multiple lesions, solitary large mass or as a mixed type of tumor. They usually show early arterial enhancement followed by progressive filling in of contrast within the lesion, contrary to washout seen in hepatocellular carcinoma [14] . The hypervascular pattern of liver angiosarcoma is usually different from other vascular tumors in the liver, such as hepatoma or hemangioma. The tumor can be solitary or multifocal, however majority of the patients have multiple lesions at the time of presentation with few large tumor masses. Non contrast scans may show areas of heterogeneity with hemorrhage. Post contrast scans show variable and non-conforming pattern of hypervascularity within and around the rim of the lesions. Equilibrium and delayed phases may show centripetal filling in of contrast in the tumor nodules. However most of these nodules still remain hypodense in contrast enhancement compared to rest of the liver parenchyma.
On MRI there is diffusion hyperintensity with variable ADC values which are higher than the mean seen in other hepatic malignancies but low ADC values compared to those seen in benign cysts and hemangiomas [15] . This case highlights the unusual imaging findings of liver angiosarcoma on dynamic enhanced CT as well as MRI with hepatocyte specific contrast with significant progression of the disease in 3 months. The imaging features of angiosarcoma with hepatocyte specific contrast which has an additional window for scanning the patient at a delayed time interval of 90-minutes or more were observed. The tumor appeared isointense and almost homogeneous compared to rest of the liver in the delayed hepatocyte specific phase. These findings steered the diagnosis towards an atypical hemangioma, rather than angiosarcoma. Hence while performing MRI with hepatocyte specific agents; it has to be kept under consideration that lesions which appear homogenous on delayed phase may not always be suggestive of benign lesions.
Angiosarcoma is FDG PET (Fluoro deoxy glucose Positron emission tomography) avid and PET is generally used for detection of distant metastases which are usually present at the time of presentation [9, 28].
Treatment & prognosis
Treatment usually depends on the stage at which the tumor is diagnosed. If the lesion is resectable, then surgery with tumor excision and partial hepatectomy is the treatment of choice [2] However due to the silent course, early distant metastases and asymptomatic nature of the disease, most of these tumors are unresectable at the time of presentation. Radiotherapy is not the therapy of choice since angiosarcoma is not known to be radio-sensitive [9] . Hence, usually, palliative chemotherapy with agents like 5-FU, carboplatin, doxorubicin, ifosfamide, paclitaxel, and bevacizumab is the most commonly used treatment option [9] . Trans-arterial chemotherapeutic embolisation has been used extensively for more aggressive tumors [16] .
Selective internal radiation therapy (SIRT) using intrahepatic arterial infusion of 90Yttrium microspheres has also been used at few centres [17, 18] .
Trans-arterial embolisation of the primary tumor is the modality of choice, when there is a risk of spontaneous bleed and tumor rupture which can further lead to tumor seedling into the peritoneum. This also helps in attaining hemodynamic stability [19, 20] .
DISCUSSION
The prognosis of primary hepatic angiosarcoma is poor. As proven in literature, untreated tumors have survival rate of not more than 6 months and median survival rate of 6 months to 2 years even after therapy [1, 4] . Resectable tumors have better prognosis than unresectable tumors. Infiltration of tumor cells into the resected tumor margin has shown poor survival rates. Higher recurrence is also seen in this group [9] . In addition, poor survival was noted in cases of hemoperitoneum due to tumor rupture [16, 14] .
Differential Diagnoses
The differential diagnoses would include hemangioma, hypervascular metastases and atypical hepatocellular carcinoma (HCC). Hemangioma is a close contender as a differential diagnosis since it exhibits arterial phase enhancement, although, with peripheral partial discontinuous nodular pattern followed by delayed centripetal filling in. A central hypodense area, within the hemangioma is seen with peripheral enhancement in more than 90% population [22] . Angiosarcomas have been confused with cavernous hemangioma since similar progressive enhancement due to multiple vascular channels interspersed with fibrous septae is seen in both tumors [21] . However the key difference remains that the attenuation of hemangioma is always close to the opacification of large vessels, like aorta, which is not usually seen in angiosarcoma [22, 23] .
Multiplicity of lesions in angiosarcoma can make its differentiation from metastases (especially hypervascular neuroendocrine lesions) a challenge. The presence of a dominant mass with smaller heterogenous soft tissue lesions may also appear similar to metastatic deposits of varying sizes. The presence of multiple associated splenic deposits is liable to further complicate the picture, however this feature itself, is a clue to the diagnosis of Angiosarcoma, which is seen to frequently metastasize to the spleen [29] . HCC usually shows classical arterial phase hypervascularity with washout in the PVP and equilibrium phases on both CT and MRI. The lesions appear hypoattenuating to rest of the liver in the delayed phases. Multifocal angiosarcoma show early arterial phase hypervascularity, with or without washout in the delayed phase. Some patients, on the contrary show partial progressive delayed enhancement.
Ultrasound shows heterogenous echogenicity in both hepatoma and angiosarcoma. Hemangiomas are usually echogenic in appearance but may sometimes appear isoechoic.
CT and dynamic MRI are the modalities of choice for investigation in today's era. TC-99m-labeled red blood cell scintigraphy is very sensitive for diagnosis of hemangioma and may be useful in differentiating angiosarcoma from large cavernous hemangiomas [25] . Triple tracer scintigraphy may be an effective diagnostic test for HCC in case of suspicion [26] .
PET (positron emission tomography) has also been used to diagnose distant spread of disease in hepatoma and angiosarcoma and rarely to diagnose these [27] .
An atypical vascular lesion in elderly patients with underlying cirrhotic liver isn't essentially representative of hepatocellular carcinoma. In the background of normal AFP, hypervascular lesions showing variable washout can represent uncommon lesions like angiosarcoma. Also, hypervascular bizarre solitary or multiple lesions showing atypical enhancement pattern not conforming to that of hemangiomas also deserve close monitoring and further investigation. Progressive centripetal contrast filling with variable heterogenous pattern could be a lead pointer to hepatic angiosarcoma [15, 24] .
Angiosarcoma of the liver is a rare mesenchymal tumor which can present in patients with underlying liver cirrhosis. In the current clinical scenario, it can present without the history of carcinogen exposure with which it is known to be associated. It has variable patterns of enhancement with a few salient distinctive imaging pointers which should be kept under consideration when reporting atypical hypervascular tumours in the liver. 
